Atlas Venture Advisors, Inc. - Q3 2022 holdings

$278 Million is the total value of Atlas Venture Advisors, Inc.'s 7 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .

 Value Shares↓ Weighting
IAS  INTEGRAL AD SCIENCE HLDNG CO$164,513,000
-27.1%
22,722,7710.0%59.26%
-16.8%
 DRAFTKINGS INC$99,252,000
+29.7%
6,555,6080.0%35.75%
+48.0%
VRDN  VIRIDIAN THERAPEUTICS INC$4,297,000
+77.3%
209,5050.0%1.55%
+102.4%
ROKU  ROKU INC$3,255,000
-31.3%
57,7070.0%1.17%
-21.6%
FSTX  F-STAR THERAPEUTICS INC$2,944,000
-18.2%
574,9960.0%1.06%
-6.7%
SNAP  SNAP INCcl a$2,411,000
-25.2%
245,5590.0%0.87%
-14.7%
LRMR  LARIMAR THERAPEUTICS INC$935,000
+63.2%
292,1840.0%0.34%
+86.2%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings